The latest study on Neuroprotection Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Neuroprotection Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Neuroprotection and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
F. Hoffmann-La Roche
Eli Lilly and Company
Daiichi Sankyo Company
Allergan
Novartis
AstraZeneca
Dr. Reddy's Laboratories
Astrocyte Pharmaceuticals
Teva Pharmaceutical Industries
Biogen
Neuroprotection Market Analysis By Type Segment:
Free Anti-Inflammatory Agents
Radical Trapping Agents (Antioxidants)
Apoptosis Inhibitors
Glutamate Antagonists (Anti-Excitotoxic Agents)
Neurotrophic Factors (NTFs)
Stimulants
Metal Ion Chelators
Other Products
Neuroprotection Market Analysis By Application Segment:
Prevention
Treatment
Neuroprotection Market Analysis By Regions (Countries):
The Neuroprotection Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Neuroprotection Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Neuroprotection Market:
Neuroprotection market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Neuroprotection Market status and future forecast.
To present the key Neuroprotection Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Neuroprotection Market Size Growth Rate by Type (2016-2027)
1.4.2 Free Anti-Inflammatory Agents
1.4.3 Radical Trapping Agents (Antioxidants)
1.4.4 Apoptosis Inhibitors
1.4.5 Glutamate Antagonists (Anti-Excitotoxic Agents)
1.4.6 Neurotrophic Factors (NTFs)
1.4.7 Stimulants
1.4.8 Metal Ion Chelators
1.4.9 Other Products
1.5 Market by Application
1.5.1 Global Neuroprotection Market Share by Application (2016-2027)
1.5.2 Prevention
1.5.3 Treatment
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Neuroprotection Market Size
2.2 Neuroprotection Growth Trends by Regions
2.2.1 Neuroprotection Market Size by Regions (2016-2027)
2.2.2 Neuroprotection Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Neuroprotection Market Size by Manufacturers
3.1.1 Global Neuroprotection Revenue by Manufacturers (2020)
3.1.2 Global Neuroprotection Revenue Market Share by Manufacturers (2020)
3.1.3 Global Neuroprotection Market Concentration Ratio (CR5 and HHI)
3.2 Neuroprotection Key Players Head office and Area Served
3.3 Key Players Neuroprotection Product/Solution/Service
3.4 Date of Enter into Neuroprotection Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Neuroprotection Market Size by Type (2016-2020)
4.2 Global Neuroprotection Market Size by Application (2016-2020)
5 United States
5.1 United States Neuroprotection Market Size (2016-2020)
5.2 Neuroprotection Key Players in United States
5.3 United States Neuroprotection Market Size by Type
5.4 United States Neuroprotection Market Size by Application
6 Europe
6.1 Europe Neuroprotection Market Size (2016-2020)
6.2 Neuroprotection Key Players in Europe
6.3 Europe Neuroprotection Market Size by Type
6.4 Europe Neuroprotection Market Size by Application
7 China
7.1 China Neuroprotection Market Size (2016-2020)
7.2 Neuroprotection Key Players in China
7.3 China Neuroprotection Market Size by Type
7.4 China Neuroprotection Market Size by Application
8 Japan
8.1 Japan Neuroprotection Market Size (2016-2020)
8.2 Neuroprotection Key Players in Japan
8.3 Japan Neuroprotection Market Size by Type
8.4 Japan Neuroprotection Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Neuroprotection Market Size (2016-2020)
9.2 Neuroprotection Key Players in Southeast Asia
9.3 Southeast Asia Neuroprotection Market Size by Type
9.4 Southeast Asia Neuroprotection Market Size by Application
10 India
10.1 India Neuroprotection Market Size (2016-2020)
10.2 Neuroprotection Key Players in India
10.3 India Neuroprotection Market Size by Type
10.4 India Neuroprotection Market Size by Application
11 Central & South America
11.1 Central & South America Neuroprotection Market Size (2016-2020)
11.2 Neuroprotection Key Players in Central & South America
11.3 Central & South America Neuroprotection Market Size by Type
11.4 Central & South America Neuroprotection Market Size by Application
12 International Players Profiles
12.1 F. Hoffmann-La Roche
12.1.1 F. Hoffmann-La Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Neuroprotection Introduction
12.1.4 F. Hoffmann-La Roche Revenue in Neuroprotection Business (2020)
12.1.5 F. Hoffmann-La Roche Recent Development
12.2 Eli Lilly and Company
12.2.1 Eli Lilly and Company Company Details
12.2.2 Company Description and Business Overview
12.2.3 Neuroprotection Introduction
12.2.4 Eli Lilly and Company Revenue in Neuroprotection Business (2020)
12.2.5 Eli Lilly and Company Recent Development
12.3 Daiichi Sankyo Company
12.3.1 Daiichi Sankyo Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Neuroprotection Introduction
12.3.4 Daiichi Sankyo Company Revenue in Neuroprotection Business (2020)
12.3.5 Daiichi Sankyo Company Recent Development
12.4 Allergan
12.4.1 Allergan Company Details
12.4.2 Company Description and Business Overview
12.4.3 Neuroprotection Introduction
12.4.4 Allergan Revenue in Neuroprotection Business (2020)
12.4.5 Allergan Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Neuroprotection Introduction
12.5.4 Novartis Revenue in Neuroprotection Business (2020)
12.5.5 Novartis Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Company Details
12.6.2 Company Description and Business Overview
12.6.3 Neuroprotection Introduction
12.6.4 AstraZeneca Revenue in Neuroprotection Business (2020)
12.6.5 AstraZeneca Recent Development
12.7 Dr. Reddy's Laboratories
12.7.1 Dr. Reddy's Laboratories Company Details
12.7.2 Company Description and Business Overview
12.7.3 Neuroprotection Introduction
12.7.4 Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2020)
12.7.5 Dr. Reddy's Laboratories Recent Development
12.8 Astrocyte Pharmaceuticals
12.8.1 Astrocyte Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Neuroprotection Introduction
12.8.4 Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2020)
12.8.5 Astrocyte Pharmaceuticals Recent Development
12.9 Teva Pharmaceutical Industries
12.9.1 Teva Pharmaceutical Industries Company Details
12.9.2 Company Description and Business Overview
12.9.3 Neuroprotection Introduction
12.9.4 Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2020)
12.9.5 Teva Pharmaceutical Industries Recent Development
12.10 Biogen
12.10.1 Biogen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Neuroprotection Introduction
12.10.4 Biogen Revenue in Neuroprotection Business (2020)
12.10.5 Biogen Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Neuroprotection Key Market Segments
Table Key Players Neuroprotection Covered
Table Global Neuroprotection Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Neuroprotection Market Size Market Share by Type 2016-2027
Figure Free Anti-Inflammatory Agents Figures
Table Key Players of Free Anti-Inflammatory Agents
Figure Radical Trapping Agents (Antioxidants) Figures
Table Key Players of Radical Trapping Agents (Antioxidants)
Figure Apoptosis Inhibitors Figures
Table Key Players of Apoptosis Inhibitors
Figure Glutamate Antagonists (Anti-Excitotoxic Agents) Figures
Table Key Players of Glutamate Antagonists (Anti-Excitotoxic Agents)
Figure Neurotrophic Factors (NTFs) Figures
Table Key Players of Neurotrophic Factors (NTFs)
Figure Stimulants Figures
Table Key Players of Stimulants
Figure Metal Ion Chelators Figures
Table Key Players of Metal Ion Chelators
Figure Other Products Figures
Table Key Players of Other Products
Table Global Neuroprotection Market Size Growth by Application 2016-2027 (Million US$)
Figure Prevention Case Studies
Figure Treatment Case Studies
Figure Neuroprotection Report Years Considered
Table Global Neuroprotection Market Size 2016-2027 (Million US$)
Figure Global Neuroprotection Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Neuroprotection Market Size by Regions 2016-2027 (Million US$)
Table Global Neuroprotection Market Size by Regions 2016-2020 (Million US$)
Table Global Neuroprotection Market Share by Regions 2016-2020
Figure Global Neuroprotection Market Share by Regions 2016-2020
Figure Global Neuroprotection Market Share by Regions 2020
Table Market Top Trends
Table Global Neuroprotection Revenue by Manufacturers (2020) (Million US$)
Table Global Neuroprotection Market Share by Manufacturers (2020)
Figure Global Neuroprotection Market Share by Manufacturers in 2020
Table Global Neuroprotection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Neuroprotection Product/Solution/Service
Table Date of Enter into Neuroprotection Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Neuroprotection Market Size by Type (2016-2020) (Million US$)
Table Global Neuroprotection Market Size Share by Type (2016-2020)
Figure Global Neuroprotection Market Size Market Share by Type (2016-2020)
Table Global Neuroprotection Market Size by Application (2016-2020) (Million US$)
Table Global Neuroprotection Market Size Share by Application (2016-2020)
Figure Global Neuroprotection Market Size Market Share by Application (2016-2020)
Figure Global Neuroprotection Revenue Market Share by Application in 2020
Figure United States Neuroprotection Market Size 2016-2020 (Million US$)
Table United States Key Players Neuroprotection Revenue (2020) (Million US$)
Table United States Key Players Neuroprotection Market Share (2020)
Table United States Neuroprotection Market Size by Type (2016-2020) (Million US$)
Table United States Neuroprotection Market Share by Type (2016-2020)
Table United States Neuroprotection Market Size by Application (2016-2020) (Million US$)
Table United States Neuroprotection Market Share by Application (2016-2020)
Figure Europe Neuroprotection Market Size 2016-2020 (Million US$)
Table Europe Key Players Neuroprotection Revenue (2020) (Million US$)
Table Europe Key Players Neuroprotection Market Share (2020)
Table Europe Neuroprotection Market Size by Type (2016-2020) (Million US$)
Table Europe Neuroprotection Market Share by Type (2016-2020)
Table Europe Neuroprotection Market Size by Application (2016-2020) (Million US$)
Table Europe Neuroprotection Market Share by Application (2016-2020)
Figure China Neuroprotection Market Size 2016-2020 (Million US$)
Table China Key Players Neuroprotection Revenue (2020) (Million US$)
Table China Key Players Neuroprotection Market Share (2020)
Table China Neuroprotection Market Size by Type (2016-2020) (Million US$)
Table China Neuroprotection Market Share by Type (2016-2020)
Table China Neuroprotection Market Size by Application (2016-2020) (Million US$)
Table China Neuroprotection Market Share by Application (2016-2020)
Figure Japan Neuroprotection Market Size 2016-2020 (Million US$)
Table Japan Key Players Neuroprotection Revenue (2020) (Million US$)
Table Japan Key Players Neuroprotection Market Share (2020)
Table Japan Neuroprotection Market Size by Type (2016-2020) (Million US$)
Table Japan Neuroprotection Market Share by Type (2016-2020)
Table Japan Neuroprotection Market Size by Application (2016-2020) (Million US$)
Table Japan Neuroprotection Market Share by Application (2016-2020)
Figure Southeast Asia Neuroprotection Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Neuroprotection Revenue (2020) (Million US$)
Table Southeast Asia Key Players Neuroprotection Market Share (2020)
Table Southeast Asia Neuroprotection Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Neuroprotection Market Share by Type (2016-2020)
Table Southeast Asia Neuroprotection Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Neuroprotection Market Share by Application (2016-2020)
Figure India Neuroprotection Market Size 2016-2020 (Million US$)
Table India Key Players Neuroprotection Revenue (2020) (Million US$)
Table India Key Players Neuroprotection Market Share (2020)
Table India Neuroprotection Market Size by Type (2016-2020) (Million US$)
Table India Neuroprotection Market Share by Type (2016-2020)
Table India Neuroprotection Market Size by Application (2016-2020) (Million US$)
Table India Neuroprotection Market Share by Application (2016-2020)
Figure Central & South America Neuroprotection Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Neuroprotection Revenue (2020) (Million US$)
Table Central & South America Key Players Neuroprotection Market Share (2020)
Table Central & South America Neuroprotection Market Size by Type (2016-2020) (Million US$)
Table Central & South America Neuroprotection Market Share by Type (2016-2020)
Table Central & South America Neuroprotection Market Size by Application (2016-2020) (Million US$)
Table Central & South America Neuroprotection Market Share by Application (2016-2020)
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Neuroprotection Business (2020) (Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Neuroprotection Business (2020)
Table F. Hoffmann-La Roche Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Neuroprotection Business (2020)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Neuroprotection Business (2020)
Table Eli Lilly and Company Recent Development
Table Daiichi Sankyo Company Company Details
Table Daiichi Sankyo Company Revenue in Neuroprotection Business (2020)(Million US$)
Figure Daiichi Sankyo Company Revenue Growth Rate in Neuroprotection Business (2020)
Table Daiichi Sankyo Company Recent Development
Table Allergan Company Details
Table Allergan Revenue in Neuroprotection Business (2020)(Million US$)
Figure Allergan Revenue Growth Rate in Neuroprotection Business (2020)
Table Allergan Recent Development
Table Novartis Company Details
Table Novartis Revenue in Neuroprotection Business (2020)(Million US$)
Figure Novartis Revenue Growth Rate in Neuroprotection Business (2020)
Table Novartis Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Neuroprotection Business (2020)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Neuroprotection Business (2020)
Table AstraZeneca Recent Development
Table Dr. Reddy's Laboratories Company Details
Table Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2020)(Million US$)
Figure Dr. Reddy's Laboratories Revenue Growth Rate in Neuroprotection Business (2020)
Table Dr. Reddy's Laboratories Recent Development
Table Astrocyte Pharmaceuticals Company Details
Table Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2020)(Million US$)
Figure Astrocyte Pharmaceuticals Revenue Growth Rate in Neuroprotection Business (2020)
Table Astrocyte Pharmaceuticals Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2020)(Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Neuroprotection Business (2020)
Table Teva Pharmaceutical Industries Recent Development
Table Biogen Company Details
Table Biogen Revenue in Neuroprotection Business (2020)(Million US$)
Figure Biogen Revenue Growth Rate in Neuroprotection Business (2020)
Table Biogen Recent Development
Table Global Neuroprotection Market Size by Regions (Million US$) 2021-2027
Figure Global Neuroprotection Market Size Share by Regions (2021-2027)
Figure Global Neuroprotection Market Size Share by Regions in 2027
Figure United States Neuroprotection Market Size Forecast (2021-2027)(Million USD)
Figure Europe Neuroprotection Market Size Forecast (2021-2027)(Million USD)
Figure China Neuroprotection Market Size Forecast (2021-2027)(Million USD)
Figure Japan Neuroprotection Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Neuroprotection Market Size Forecast (2021-2027)(Million USD)
Figure India Neuroprotection Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Neuroprotection Market Size Forecast (2021-2027)(Million USD)
Table Global Neuroprotection Market Size by Product (2021-2027) (Million US$)
Figure Global Neuroprotection Market Size by Product (2021-2027)
Figure Global Neuroprotection Market Size by Product in 2027
Table Global Neuroprotection Market Size by Application (2021-2027) (Million US$)
Figure Global Neuroprotection Market Size by Application (2021-2027)
Figure Global Neuroprotection Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources